retatrutide kidney function Diagram showing the mechanism of action of Next-generation therapeutics for diabetic kidney

Beneficiaries must be enrolled in a Part D plan and meet clinical criteria (BMI 30+ or BMI 27+ with a weight-related condition)

Weeks of no progress on the scale, after experiencing the dopamine hit of consistent losses, can trigger frustration, self-doubt, disordered eating behaviors, and the temptation to make drastic changes that often backfire

Our team is skilled at determining whether an insurer will cover options like Wegovy or Zepbound

Yes, tirzepatide should be discontinued when pregnancy is recognized or before planned conception

Regular check-ins ensure safe and effective progress throughout treatment

They can assess your individual risk profile, review your current medications for potential interactions, and refer you to specialist services where appropriate